Home
    Disclaimer
    BOD molecular structure

    BOD Stats & Data

    NPS DataHub
    MW225.29
    FormulaC12H19NO3
    CAS98537-41-8
    IUPAC2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethanamine
    SMILESCOC(CN)c1cc(OC)c(C)cc1OC
    InChIKeyVTEIFHQUZWABDE-UHFFFAOYSA-N
    Phenethylamines; 2020/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2021/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2022/1. Von 2-Phenethylamin abgeleitete Verbindungen
    Psychoactive Class Psychedelic

    Effect Profile

    Curated + 9 Reports
    Psychedelic 3.1

    Mild visuals with low body load and headspace

    Visual Intensity×3
    4
    Headspace Depth×3
    2
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    3

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid
    9 Reports
    2012–2022 Date Range
    8 With Age Data
    14 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 9 experience reports (9 Erowid)

    9 Reports
    14 Effects Detected
    8 Positive
    3 Adverse
    3 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 8

    Color Enhancement 88.9% 70%
    Stimulation 77.8% 70%
    Euphoria 77.8% 70%
    Empathy 55.6% 70%
    Introspection 44.4% 70%
    Music Enhancement 44.4% 70%
    Focus Enhancement 44.4% 70%
    Tactile Enhancement 33.3% 70%

    Adverse Effects 3

    Nausea 55.6% 70%
    Muscle Tension 55.6% 70%
    Anxiety 44.4% 70%

    Real-World Dose Distribution

    62K Doses

    From 10 individual dose entries

    Oral (n=10)

    Median: 20.95mg 25th: 15.0mg 75th: 28.75mg 90th: 30.1mg
    mg/kg median: 0.265 mg/kg 75th: 0.348

    Common Combinations

    Most co-occurring substances in experience reports

    Form / Preparation

    Most common forms and preparations reported

    ← Back to BOD